baber/WOPTO huggingface dataset:
Patent NZ-201642-A (NZ)
Title: 1-phenylindazol-3-one derivatives and pharmaceutical compositions
Inventor: HEINEMANN H
IPC: C07D401/12
Filed: 1982-08-19
Abstract: Compounds corresponding to the formula:    <IMAGE>  II  wherein R1 and R3 each represent hydrogen, halogen, lower alkyl, lower alkoxy or trifluoromethyl; R2 and R4 each represent hydrogen, halogen, lower alkyl or lower alkoxy; Z represents an alkylene radical with 2 to 6 carbon atoms and Y'' is halogen, hydroxyl, lower alkanesulphonyl, benzenesulphonyl, or lower alkyl or halogen substituted benzenesulphonyl, and acid addition salts thereof, with the proviso the Y'' is other than chlorine if R1, R2, R3 and R4 each are hydrogen and Z is ethylene or propylene. The claimed compounds are useful intermediates in the synthesis of 1-phenyl-2-[(4-substituted piperazinyl) alkyl]-1,2-dihydro-3H-indazol-3-ones which exhibit antiallergic activity.
Patent NZ-209789-A (NZ)
Title: Fluidised bed waste water treatment reactor;external access to individual fluidising pipes
Inventor: MACLEAN G W
IPC: B01J8/20
Filed: 1984-10-05
Abstract: A fluidised bed waste water treatment reactor which includes a reactor tank (10) containing a particulate media, an array of perforated distribution pipes (29) disposed in a horizontal, parallel array adjacent the bottom of the reactor tank (10), for introducing fluidising liquid substantially uniformly over the cross-sectional area of the reactor tank (10). The arrangement is characterized in that an inlet end of each of the distribution pipes (29) extends externally of the reactor tank (10) and the distribution pipes (29) are connected together by a header tank (16) positioned externally of the reactor tank (10). This arrangement allows access externally of the reactor tank (10) to individual distribution pipes (29) which allows blockages of the pipes (29) to be readily cleared.
Patent NZ-221895-A (NZ)
Title: Composition and method for the diagnosis of pseudomonas aeruginosa infections
Inventor: YOUNG LOWELL S
IPC: G01N33/569
Filed: 1987-09-22
Abstract: The present invention provides novel compositions and methods useful in the diagnosis and monitoring of Gram-negative infection, especially chronic Pseudomonas aeruginosa infection associated with cystic fibrosis. Pseudomonas aeruginosa strain PAC 605 core lipopolysaccharide determinants are employed as a solid phase antigen in enzyme linked immunosorbant assays and Western blot immunoassay to measure human IgG response to P. aeruginosa infection. The novel compositions are provided in kit form for use in assay methods according to the present invention.
Patent NZ-223549-A (NZ)
Title: Macromolecular antitumour compositions containing platinum
Inventor: SERINO A J
IPC: A61K47/36
Filed: 1988-02-17
Abstract: Novel composition of platinum-containing macromolecules for targeting by tumor-selective agents, such as monoclonal antibodies, or for sustained or controlled release in the treatment of tumor cells.
Patent NZ-230817-A (NZ)
Title: Polypeptide antigen corresponding to plasmodium falciparum circumsporozoite protein
Inventor: ELLIS JOAN
IPC: C07K7/02
Filed: 1985-07-22
Abstract: A protective peptide antigen corresponding to Plasmodium falciparum circumsporozoite. A DNA encoding the peptide is also disclosed. The peptide tandemly repeats at least twenty three times and comprises eptopes of Plasmodium falciparum CS protein.
Patent NZ-232542-A (NZ)
Title: N-phenyl-n-(4-piperidinyl)amide derivatives; preparatory processes and pharmaceutical compositions
Inventor: FELDMAN PAUL L
IPC: C07D211/14
Filed: 1990-02-14
Abstract: N-Phenyl-N-(4-piperdinyl)amide derivatives are disclosed having the general formula (I). <CHEM>  wherein:  X is a member selected from the group consisting of:  alkoxy-carbonyl-lower alkyl,  lower alkyl-carbonyloxy-lower alkyl,  alkenyloxy-carbonyl-lower alkyl, and  (C1-2)alkoxy-(C1-2)alkoxy-carbonyl-lower alkyl. Ar is a member selected from the group consisting of phenyl, mono-, di- and tri-substituted phenyl, wherein each subtitutuent is independently selected from the group consisting of halo, lower alkyl, lower alkoxy and trifluoromethyl; R is a member selected from the group consisting of lower alkyl, and lower alkoxy-lower alkyl; R<1> is a member selected from the group consisting of hydrogen, lower alkoxy-carbonyl, and methoxymethyl; and R<2> is a member selected from the group consisting of hydrogen and methyl; and the diastereomeric and enantiomeric isomers thereof, and the acid addition salts of said compounds and isomers. The compounds exhibit analgesic activity having relatively short durations of analgesic action. The invention embraces the compounds (I), pharmaceutical compositions of (I) and methods of providing analgesia with (I). Also included are certain novel intermediates for making (I).
Patent NZ-238298-A (NZ)
Title: Ortho-substituted benzyl ester of cyclopropane carboxylic acid, fungicidal and pesticidal agents thereof
Inventor: SCHUETZ FRANZ
IPC: C07C69/743
Filed: 1991-05-29
Abstract: Ortho-substituted benzyl esters of cyclopropanecarboxylic acids I <IMAGE>  (X = N, CH> where A is one of the following cyclopropane radicals: <IMAGE> (R<1> is CN, C2-C8-alkyl, CF3, C3-C8-alkenyl, C1-C4-alkoxycarbonyl, optionally substituted phenyl-C1-C6-alkyl or phenyl-C3-C6-alkenyl, ethoxyphenyl, 2- or 3-bromophenyl, 2- or 4-trifluoromethylphenyl, 2,4- or 2,6-difluorophenyl, 2-fluoro-6-chlorophenyl, 2,4- or 2,6-dimethylphenyl, 2,3,6-trichlorophenyl, trimethylsilyl; R<2> is H or halogen; R<3> is optionally substituted phenyl; R<4> is CH3 or halogen; Hal is halogen),  with the proviso that X is CH when R<1> is CF3 or trimethylsilyl. The compounds I are suitable as fungicides and for controlling pests.
Patent NZ-243467-A (NZ)
Title: Process for preparing maleic anhydride using a fixed bed catalyst
Inventor: EBNER JERRY RUDOLPH
IPC: C07D307/60
Filed: 1992-07-07
Abstract: An improved process for the manufacture of maleic anhydride by catalytic oxidation of a nonaromatic hydrocarbon having at least four carbon atoms in a straight chain, in which a gas containing oxygen and hydrocarbon is passed through a fixed catalyst bed in a tubular reactor. The activity of the catalyst bed is graded in such manner that the reactor can be operated at an initial (feed gas) hydrocarbon concentration of over 1.5% by volume, an integrated average temperature difference between gas and cooling fluid of at least about 15 DEG  C. over that portion of the bed in which the gas temperature exceeds the cooling fluid temperature, and a productivity of at least about 5.0 lbs. maleic anhydride per hour, without the temperature difference between the gas and the cooling fluid exceeding 80 DEG  C. at any point in the catalyst bed during the course of the reaction. Preferably, the catalyst activity and the gas permeability of the bed vary in the direction of gas flow so that both the catalyst activity and the pressure drop per unit distance are lower in a critical region, where the combination of temperature and hydrocarbon concentration could otherwise cause the reaction to proceed at an excessive rate, than they are in a region of low temperature and low hydrocarbon concentration. Significant and unexpected improvement in reactor performance is achieved by the combination of a graded catalyst charge and incorporation of a catalyst modifying organophosphorus compound in the hydrocarbon feed.
Patent NZ-247249-A (NZ)
Title: Benzoxazinone and benzothiazinone derivatives; medicaments and use
Inventor: SALA ALBERTO
IPC: C07D413/04
Filed: 1993-03-25
Abstract: 2,3-dihydro-4H-1,3-benzoxazin-4-ones and 2,3-dihydro-4H-1,3-benzothiaxin-4-ones of formula I <CHEM> wherein R represents hydrogen, (C1-6)alkyl, (C5-7)cycloalkyl, phenyl, phenyl substituted by hydroxy, halogen, nitro, (C1-6)alkyl, (C1-6)alkoxy, methylenedioxy; R1 and R2 independently represent hydrogen, amide, amino, carboxy, hydroxy, nitro, ciano, mercapto; X is an oxygen or sulphur atom; Y is a (C2-6)alkylene chain or (C2-6)cycloalkylene group; and the pharmaceutically acceptable acid or basic salts thereof.
Patent NZ-253130-A (NZ)
Title: Pharmaceutical compositions of glutathione and an antitumour drug active on the mitotic spindle
Inventor: CAVALLETTI ENNIO
IPC: A61P43/00
Filed: 1993-06-14
Abstract: PCT No. PCT/EP93/01494 Sec. 371 Date Dec. 22, 1994 Sec. 102(e) Date Dec. 22, 1994 PCT Filed Jun. 14, 1992 PCT Pub. No. WO94/00141 PCT Pub. Date Jan. 6, 1994The use of glutathione (GSH) as chemoprotective agent against neurotoxicity induced by antitumor drugs active on the mitotic fuse is herein described.
Patent NZ-271820-A (NZ)
Title: Neck clip bottle carrier; two clip units with inner and outer plies connected by a central handle
Inventor: FOGLE JAMES C
IPC: B65D71/28
Filed: 1994-08-11
Abstract: A neck clip carrier comprised of two carrier units separated by a handle structure. Each carrier unit is comprised of a bottom panel and two angled side panels. The bottom panels and side panels contain openings for receiving two bottles, the lower edge of the side panel openings engaging the underside of the bottle flanges to support the bottles. The handle structure comprised of spaced panels hinged together at their upper edges, and the bottom and side panels of the carrier units are of two-ply construction. Tear strips may be provided in the plies of the outer side panels to facilitate access to the bottles. The carrier is formed from a single blank of material.
Patent NZ-276881-A (NZ)
Title: Process for separating ink particles from recycled waste paper using a higher and a lower rotational speed in different blending stages
Inventor: MARKHAM LARRY DERWOOD
IPC: D21B1/32
Filed: 1994-11-04
Abstract: A process for separating printing ink from recycled paper fiber includes the steps of repulping recycled paper furnish with water in a rotary mixer for about 5 minutes at a consistency of 6% to 18% with a mixing element having a top speed no greater than 2,000 ft/min. This first stage repulping and mixing is followed by a second mixing stage of 20 to 45 minutes with a mixing element tip speed of 2,500 to 4,000 ft/min. Agglomerated contamination particles in the resulting slurry are removed by centrifugal cleaning and slot screening.
Patent NZ-312121-A (NZ)
Title: Pharmaceutical compositions comprising an intestinal eubiotic bacterial strain and glutamine
Inventor: DE HAEN CHRISTOPH
IPC: A61K35/74
Filed: 1996-06-19
Abstract: PCT No. PCT/EP96/02650 Sec. 371 Date Dec. 12, 1997 Sec. 102(e) Date Dec. 12, 1997 PCT Filed Jun. 19, 1996 PCT Pub. No. WO97/00688 PCT Pub. Date Jan. 9, 1997The present invention refers to pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders.
Patent NZ-332223-A (NZ)
Title: Electrostatic chuck for positioning particles on a substrate
Inventor: SUN HOI CHEONG STEVE
IPC: B23B/
Filed: 1997-04-09
Abstract: A method of positioning multiple objects in a selected configuration on a substrate involves aligning an electrostatic chuck 230 with the objects 260 electrostatically attracted to the chuck in a set of discrete locations.  The objects are then released from the chuck onto the substrate.  The objects may be particles of a pharmaceutical powder.
Patent NZ-332819-A (NZ)
Title: A nasal dilator and a method of producing same
Inventor: DE VOSS TORSTEN
IPC: A61F5/56
Filed: 1997-04-16
Abstract: PCT No. PCT/DK97/00164 Sec. 371 Date Jun. 12, 1997 Sec. 102(e) Date Jun. 12, 1997 PCT Filed Apr. 16, 1997 PCT Pub. No. WO97/38651 PCT Pub. Date Oct. 23, 1997A nasal dilator (10'') for placing on a user's nose and for improving respiration through the nose by dilation of the user's nostrils comprises a central, resilient, beam-shaped element (12) and two attaching elements (14 and 16) placed at respective ends of the beam-shaped element for attachment to respective sides of the user's nose. The beam-shaped element (12) extends in use from one side of the user's nose across the bridge of the user's nose to the other side of the user's nose and the central, resilient, beam-shaped element (12) and the two attaching elements (14, 16) are integrally made of plastic. The nasal dilator (10'') constitutes a configuration which is symmetrical relative to a central plane perpendicular to the longitudinal axis of the beam-shaped element and preferably constitutes an overall curved structure or alternatively a substantially plane structure. The central, resilient, beam-shaped element exhibits a rigidity increasing from the central plane towards the two attaching elements (14, 16) and the two attaching elements constitute substantially, plane, flat-shaped elements constituting extensions of the central, resilient, beam-shaped element (12) to which attaching elements a skin-compatible adhesive (20) is applied.
Patent NZ-502810-A (NZ)
Title: Treatment of oppositional defiant disorder with norepinephrine reuptake inhibitors
Inventor: HEILIGENSTEIN JOHN HARRISON
IPC: A61K31/135
Filed: 1998-09-01
Abstract: Oppositional defiant disorder may be treated with a norepinephrine reuptake inhibitor. Particularly preferred norepinephrine reuptake inhibitors are tomoxetine, reboxetine, duloxetine, venlafaxine, milnacipran, and a compound of formula I, wherein X is C1-C4 alkylthio, and Y is C1-C2 alkyl.
Patent NZ-504164-A (NZ)
Title: Compressed gas propelled aerosol devices capable of reducing the droplet size of its emission
Inventor: FOX RODNEY THOMAS
IPC: B05B5/16
Filed: 1998-10-23
Abstract: A method of reducing the droplet size of a composition sprayed from an aerosol spray device comprising a compressed gas propellant, which method comprises imparting a unipolar charge to the liquid droplets by double layer charging during the spraying of the liquid droplets from the aerosol spray device, the unipolar charge being at a level such that the said droplets have a charge to mass ratio of at least +/- 1 x 10-4 C/kg.
Patent NZ-512038-A (NZ)
Title: Improvements in and relating to an animal marking system
Inventor: BUCKLEY PAUL FLEMING
IPC: A61D7/00
Filed: 2001-05-29
Abstract: A method of treating a non-human animal with a single animal treatment device, including: a primary treatment, and a secondary treatment which is adapted to identify an animal about to receive the primary treatment, characterised by the step of applying the secondary treatment with the device prior to applying the primary treatment with the same device. Also disclosed is an animal treatment device (1) for applying a primary treatment and a secondary treatment, including: an actuator, a primary treatment applicator (7) and a secondary treatment applicator (6), characterised in that the treatment device is configured such that as the primary treatment is initiated, the actuator mechanism activates the application of the secondary treatment prior to the application of the primary treatment.
Patent NZ-512385-A (NZ)
Title: Process for production of wood composites using a mixed PMDI/solid novolac resin binder
Inventor: ROSTHAUSER JAMES W
IPC: C08G18/64
Filed: 1999-12-10
Abstract: A process for the production of wood composite materials is disclosed where wood particles are combined with 1 to 25% by weight, based on the total weight of the wood composite, of a binder composition consisting essentially of a polymethylene poly(phenylisocyanate) having a functionality of about 2.1 to about 3.5, and NCO group content of from about 25 to 33%, and a monomer content of from about 30% to 90% by weight, where the content of the monomer comprises up to about 5% by weight of the 2,2'-isomer, from about 1% up to about 20% by weight of the 2,4'-isomer, and from about 25% to about 65% by weight of the 4,4'-isomer, based on the entire weight of the polyisocyanate; and a solid novolac resin, and molding or compressing the combination formed, thus forming the wood composite material.
Patent NZ-515725-A (NZ)
Title: Method and apparatus for detecting mastitis by using visible light and/or near infrared light
Inventor: TSENKOVA ROUMIANA
IPC: G01N21/359
Filed: 2001-03-14
Abstract: A method for diagnosing mastitis of cows, includes the steps of (1) irradiating visual light rays and/or near infrared rays in a wavelength range of 400 to 2500 nm into urine, raw milk or a mammary gland of a cow, (2) detecting an intensity of transmitted light rays, reflected light rays or transmitted and reflected light rays from said urine, raw milk or mammary gland, and (3) effecting multivariate regression analysis, and (4) diagnosing the presence of the mastitis of the cow.
Patent NZ-516161-A (NZ)
Title: Insect bait-and-switch delivery apparatus
Inventor: SOLLER DOUGLAS A
IPC: A01M1/20
Filed: 2000-06-07
Abstract: An insect bait-and-switch liquid delivery apparatus is disclosed for the control of insects. The apparatus includes a reservoir 2 defining a first chamber 6 containing liquid bait attractive to an insect and a second chamber 7 containing liquid active toxic to an insect, a first feeding station 6 in the first chamber for making liquid bait available to an insect, a second feeding station in the second chamber 7 for making liquid active available to an insect, a passageway interconnecting the first and second chambers, and an access port 20 disposed to initially prevent or limit access of an insect to the second feeding station during an initial feeding period and to subsequently enable access to the second feeding station via the passageway after the initial feeding period. In one embodiment, the access port is located beneath the surface of the liquid bait, and in another embodiment the access port is located above the surface of said liquid bait.
Patent NZ-524501-A (NZ)
Title: Inhalation device
IPC: A61M15/00
Filed: 1998-10-23
Abstract: A medicament inhalation device including a housing having a through-going pathway connecting an air inlet with an air outlet, a medicament reservoir adapted to receive a compacted body of powdered medicament, an inner mandrel around which the medicament reservoir rotates and metering means for dispensing a predetermined dose of medicament from the reservoir into the pathway, the metering means including means for abrading the compacted body; characterized in that there is provided between the medicament reservoir and the inner mandrel of the device a sealing means extending round less than 360 degrees of the mandrel.
Patent NZ-530289-A (NZ)
Title: Pharmaceutical composition comprising cetirizine and pseudoephedrine that contains less than 5% or no alkalinising agent
Inventor: FANARA DOMENICO
IPC: A61K31/495
Filed: 2002-06-10
Abstract: A tablet comprising two distinct segments is described; one segment of which comprises as active ingredient predominantly cetirizine and a second segment of which comprises as active ingredient predominantly pseudoephedrine. The segments are composed and formed in such a way that the resulting tablet is substantially free of impurities formed by reaction of cetirizine with pseudoephedrine and the interfacial surface area of the pseudoephedrine segment and the cetirizine segment is less than 180mm2, and with the proviso that the tablet comprises less than 5 % by weight, relative to the total weight of the tablet, of an alkalinizing agent. The tablets are used in the treatment of allergic disorders.
Patent NZ-531817-A (NZ)
Title: Enhanced electrical motor driven nail gun
Inventor: PEDICINI CHRISTOPHER S
Filed: 2002-12-18
Abstract: A portable electric nailing gun (1) operated from a power supply (3). The motor (4) accelerates a flywheel (6) which at the appropriate energy state is coupled through a mechanism to an anvil (11) acting directly on the nail (12). The actuation is governed by a control circuit (9) and initiated from a trigger switch (10). The motor (4) accelerates a flywheel (6) that is then clutched to the output anvil (11) causing the nail (12) to be driven. The position of the output anvil (11) is sensed and once the nail (12) is driven, the motor is dynamically braked reducing the excess energy in the flywheel (6). This method uses an intermediate link in the drive train and a position sensitive nailing mechanism to reduce wear and increase robustness of the nailer. The electrical control circuit (9) and brake allow precise control and improve safety. The power supply (3) is preferably a rechargeable low impedance battery pack.
Patent NZ-533718-A (NZ)
Title: Marine steering assembly
Inventor: JOHNS IAN
IPC: B63H25/04
Filed: 2004-06-23
Abstract: A marine steering assembly having a steering wheel pedestal and an upright steering output member with a manual steering mechanism retained by the steering wheel pedestal for manual control of the steering output member. An auto-pilot drive for automatic control of the steering output member, wherein the auto-pilot drive is located adjacent the steering output member and is connected directly by gearing to the steering output member, the gearing being rotatable by the output of the auto-pilot drive in order to rotate the steering output member.
Patent NZ-536692-A (NZ)
Title: Composite strip windable to form a helical pipe and method therefor
Inventor: BATEMAN IAN ROGER
IPC: B29C48/12
Filed: 2003-04-17
Abstract: A composite strip (10) is disclosed that is able to be wound to form a helical pipe is disclosed. The composite strip (10) comprises: an elongate plastic strip (11) having a base portion (12) and at least one lengthwise extending rib portion (20) upstanding from the base portion (12); and an elongate reinforcing strip (30) extending lengthwise and supported laterally by the rib portion (20), the reinforcing strip (30) having a height to thickness ratio of at least three to one and orientated substantially perpendicular to the base portion (12). When wound into a helical pipe, the reinforcing strip (30) reinforces the pipe against radial crushing loads. A bead (40) seals the reinforcing strip (30) from the environment. Desirably the composite strip (10) further comprises: a planar lamina (not shown) extending lengthwise and bonded to the base portion (12), the lamina having a higher Young's modulus and strength than those of the plastic strip (11). The lamina is stated to greatly improves the pressure rating of a pipe wound from the strip (10).
Patent NZ-536738-A (NZ)
Title: Pharmaceutically-acceptable acid addition salts of certain methoxy- and ethoxy- amidine compounds, pharmaceutical formulations containing such salts and processes for obtaining them
Inventor: AHLQVIST MATTI
IPC: A61P43/00
Filed: 2003-05-27
Abstract: Disclosed are pharmaceutically-acceptable sulfonic acid addition salts in at least a partially crystalline form of a compound of formula I wherein: R1 represents C1-2 alkyl substituted by one or more F substituents; R2 represents C1-2 alkyl; and n represents 0, 1 or 2. Salts of the type disclosed are useful for the treatment of diseases where inhibition of thrombin is required.
Patent NZ-537747-A (NZ)
Title: Nano-structured silicate, functionalised forms thereof, preparation and uses
Inventor: JOHNSTON JAMES H
Filed: 2005-01-18
Abstract: Disclosed is a nano-structured calcium silicate material which comprises nano-size platelets about 5-10 nm thick and about 50-500 nm wide stacked together in a poorly-ordered open framework type structure to provide pores which are accessible and a consequent high pore volume. Also disclosed is a process for production of the nano-structured calcium silicate material.
Patent NZ-539397-A (NZ)
Title: Guardrail with impact slider assembly with first and second rails being gathered and retained via telescopic overlap
Inventor: JAMES DALLAS
Filed: 2004-09-22
Abstract: During an end on impact first rail 3 and second rail 5 can be gathered and retained by surrounding slider 4 during telescopic sliding of the rails.